9 results
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
#Antianginal #Medications ... #Cardiology #Pharmacology ... #Management #Therapy ... #Table #Overview
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... treatment #medications ... #table #pharmacotherapy ... #decisionaid #cardiology
High yield pharmacology notes
#pharmacology #cardiology #management #medications #criticalcare #treatment
High yield pharmacology ... notes #pharmacology ... #cardiology #management ... #medications #criticalcare
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
Shock - Differential ... Failure, Toxins/Medications ... #Diagnosis #criticalcare ... #algorithm #treatment ... #management
Vasopressors and Inotropes
 • Norepinephrine - Levophed - "Levo" - Generally thought of as the first
Vasopressors #Inotropes #management ... #criticalcare # ... summary #comparison #table ... #pharmacology # ... indications
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
#diagnosis #differential ... #algorithm #management ... #table #foamed ... heartfailure #chf #criticalcare ... icu #clinical #pharmacology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... event, follow ACC algorithm ... Stable patients ... one post op Cardiology ... medical and surgical management
Perhaps quite too often, the knee-jerk reaction to an elevated Troponin is to call our friends
are typically able ... Cardiology cannot ... #diagnosis #algorithm ... #management #clinical ... #criticalcare #
Perhaps quite too often, the knee-jerk reaction to an elevated Troponin is to call our friends
are typically able ... Cardiology cannot ... #diagnosis #management ... l#foamed #algorithm ... #criticalcare